7, Sangdo-ro, Dongjak-gu, Seoul, Korea 06955   Tel : 02)8288-114   Fax : 02)8288-029   CS : 02)8288-114

Copyright © 2015 Bukwang Pharmaceutical Co., Ltd.All Rights Reserved.

  • Facebook Basic Square
  • Google+ Basic Square
NEWS

Bukwang’s antiviral drug, Levovir®, confirms antiviral effect against coronavirus

[March 10, 2020]

Bukwang Pharmaceutical Co., Ltd. announced that in vitro study of Levovir® against virus isolated from Korean patients with coronavirus infection-19 (COVID-19) showed comparable antiviral effect to KALETRA®, which is currently being used for treating COVID-19. Based on these results, the company has filed a patent application. Levovir® showed antiviral effect comparable to KALETRA® in both the plaque reduction test and RT-PCR (Real...

R&D

Bukwang’s antiviral drug, Levovir®, confirms antiviral effect against coronavirus

[March 10, 2020]

Bukwang Pharmaceutical Co., Ltd. announced that in vitro study of Levovir® against virus isolated from Korean patients with coronavirus infection-19 (C...

PRODUCTS
COMPANY

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a health...

|    ​Korean    |